RECORNEA

At RECORNEA we reinstate optimal vision in 15+ M patients suffering of Keratoconus, a progressive eye disease causing distorted vision. Both current ocular surgeries and devices are not effective in reinstating a predictable, uniform and stable-in-time shape of the cornea leading to a very poor quality of vision and life for these patients. We develop the GROSSO® Implant, the first corneal metal implant to restore the physiological curvature of the cornea with clear and predictable clinical outcomes. Product and production process fully defined and ready to start the Clinical Trials. Emiliano Lepore has a PhD in structural engineering with 10 years experience in innovation and business development in medtech and biotech. Emiliano has co-invented and is a co-owner of two licensed patents. He holds IP related to the device we are working on at RECORNEA. Kakanga Moses completed a PhD the National University of Singapore where he specialized in biotechnology and biosensor design. Moses has 10 + years in conducting clinical trials for both medical devices and bio-pharmaceuticals. He will be in charge of conducting clinical trials and product development.